Insulet | PODD - Capital De Empréstimo

Preço das Ações
172.14
Mudança Diária
12.12 7.57%
Mensal
-17.97%
Anual
-31.21%
Q2 Previsão
185.50




Capital De Empréstimo Alterar Data
Abbott USD 29.64B 19.74B 2026-03
Align Technology USD 0 0 2024-12
AtriCure USD 61.86M 0 2025-12
Avanos Medical USD 90.3M 3.1M 2025-12
Baxter International USD 8.62B 852M 2026-03
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 11.01B 19M 2025-12
Cardinal Health USD 8.25B 102M 2026-03
Cooper Companies USD 1.88B 578.5M 2025-12
Dexcom USD 1.3B 54.4M 2026-03
Edwards Lifesciences USD 600M 1.7M 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
Globus Medical USD 436K 9K 2025-12
ICU Medical USD 1.27B 48.01M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
J&J USD 37.53B 1.91B 2026-03
Masimo USD 518M 41.1M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 735.16M 1.12M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Solventum Corp USD 5.04B 102M 2025-12
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
West Pharmaceutical Services USD 202.8M 0 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03